Impaired cellular and humoral immunity is a feature of Diamond-Blackfan anaemia; experience of 107 unselected cases in the United Kingdom.
Deena IskanderIrene RobertsClare ReesRichard SzydloMary AlikianMichael NealeYvonne HarringtonPeter KelleherAnastasios KaradimitrisJosu de la FuentePublished in: British journal of haematology (2019)
Diamond-Blackfan anaemia (DBA) is a rare bone marrow failure syndrome characterised by anaemia, congenital anomalies and cancer predisposition. Although infections are the second leading cause of mortality in non-transplanted patients, immune function is largely unexplored. We identified quantitative deficits in serum immunoglobulins and/or circulating T, natural killer and B lymphocytes in 59 of 107 unselected patients (55·1%) attending our centre over a 7-year period. Immune abnormalities were independent of ribosomal protein genotype and arose in both steroid-treated and steroid-untreated patients. In summary, these data highlight the high prevalence and spectrum of infections and immune defects in DBA.
Keyphrases
- end stage renal disease
- newly diagnosed
- ejection fraction
- bone marrow
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- immune response
- traumatic brain injury
- type diabetes
- squamous cell carcinoma
- risk factors
- small molecule
- coronary artery disease
- patient reported outcomes
- tertiary care
- big data
- artificial intelligence
- cardiovascular events